Laurus Labs Reports 19.46% Increase in Q4 Net Profit for March 2026
Laurus Labs consolidated net profit rises 19.46% in the March 2026 quarter
Business Standard
Image: Business Standard
Laurus Labs, a pharmaceutical company, reported a 19.46% increase in net profit to ₹279.14 crore for the quarter ending March 2026, compared to ₹233.67 crore in the same quarter last year. Sales rose 5.31% to ₹1,811.57 crore, reflecting strong annual growth of 148.04% in net profit for the fiscal year.
- 01Laurus Labs' net profit increased by 19.46% in Q4 March 2026.
- 02Sales rose 5.31% to ₹1,811.57 crore in the same quarter.
- 03For the full fiscal year, net profit surged 148.04% to ₹888.79 crore.
- 04Annual sales increased by 22.67% to ₹6,812.90 crore.
- 05The company's operational performance improved significantly year-over-year.
Advertisement
In-Article Ad
Laurus Labs, a leading pharmaceutical company, reported a 19.46% rise in consolidated net profit for the quarter ending March 2026, reaching ₹279.14 crore compared to ₹233.67 crore in the previous year. This growth is attributed to a 5.31% increase in sales, which totaled ₹1,811.57 crore for the quarter, up from ₹1,720.30 crore in March 2025. For the fiscal year ending March 2026, Laurus Labs saw an impressive 148.04% increase in net profit, amounting to ₹888.79 crore, compared to ₹358.32 crore in the previous year. Annual sales also rose by 22.67%, reaching ₹6,812.90 crore, up from ₹5,553.96 crore in March 2025. The company's operational performance, indicated by a rise in profit before tax and other metrics, reflects its strong market position and growth strategy.
Advertisement
In-Article Ad
The significant profit growth indicates a strong performance which may lead to increased investor confidence and potential job growth within the company.
Advertisement
In-Article Ad
Reader Poll
How do you view the financial performance of Laurus Labs?
Connecting to poll...
More about Laurus Labs
Read the original article
Visit the source for the complete story.